BioNTech SE is 2.4x more valuable than Krystal Biotech, Inc. by market capitalization ($22.18 B vs $9.21 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | KRYS | BNTX |
|---|---|---|
| Market cap | $9.21 B | $22.18 B |
| US-listed rank | #989 | #582 |
| Revenue (latest FY) | $389.13M | - |
| Net income (latest FY) | $204.83M | - |
| Net margin | 52.6% | - |
| P/E (trailing FY) | 45.0 | - |
| SEC filings | 483 | 548 |
BioNTech SE is 2.4x more valuable than Krystal Biotech, Inc. by market capitalization ($22.18 B vs $9.21 B).
Full pages: Krystal Biotech, Inc. and BioNTech SE, or browse the full rankings.